Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis

被引:0
作者
Anquan Shang
Chenzheng Gu
Weiwei Wang
Xuan Wang
Junjun Sun
Bingjie Zeng
Chen Chen
Wenjing Chang
Yili Ping
Ping Ji
Junlu Wu
Wenqiang Quan
Yiwen Yao
Yongxin Zhou
Zujun Sun
Dong Li
机构
[1] Shanghai Tongji Hospital,Department of Laboratory Medicine
[2] Tongji University School of Medicine,Department of Pathology
[3] The Sixth People’s Hospital of Yancheng City,Department of Pharmacy
[4] Putuo People’s Hospital,Department of Internal Medicine V
[5] Tongji University School of Medicine,Pulmonology, Allergology
[6] Respiratory Intensive Care Medicine,Department of Thoracic
[7] Saarland University Hospital,cardiovascular Surgery
[8] Shanghai Tongji Hospital,undefined
[9] Tongji University School of Medicine,undefined
来源
Molecular Cancer | / 19卷
关键词
Colorectal cancer; Exosome; circPACRGL; miR-142-3p; miR-506-3p; TGF-; Invasion; Migration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 101 条
[1]  
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]  
Bray F(2015)Colorectal cancer Nat Rev Dis Primers 1 15065-73
[3]  
Siegel RL(2004)Adjuvant treatment of colorectal cancer Surg Oncol 13 63-21
[4]  
Ferlay J(2006)Exosomes: a common pathway for a specialized function J Biochem 140 13-579
[5]  
Lortet-Tieulent J(2002)Exosomes: composition, biogenesis and function Nat Rev Immunol 2 569-454
[6]  
Jemal A(2019)The role of exosomal noncoding RNAs in cancer Mol Cancer 18 37-7256
[7]  
Kuipers EJ(2015)Exosomes in cancer: small particle, big player J Hematol Oncol 8 83-984
[8]  
Grady WM(2011)Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments Semin Immunopathol 33 441-e258
[9]  
Lieberman D(2019)Hsa_circ_0136666 promotes the proliferation and invasion of colorectal cancer through miR-136/SH2B1 axis J Cell Physiol 234 7247-358
[10]  
Beretta GD(2018)RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer J Exp Clin Cancer Res 37 325-264